EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor‐Targeted FABP5/STING Cascade Promote Radiofrequency Ablation Induced Ferroptosis and Intratumoral Immune Rewiring in Hepatocellular Carcinoma

Bufu Tang, Xiaojie Zhang, Yiting Sun, Jinhua Luo, Qiaoyou Weng, Cong Zhang, Zilin Wang, Shiji Fang, Yangrui Xiao, Liyun Zheng, Jianfei Tu, Rongfang Qiu und 5 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202507864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Bufu Tang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Csaenter of Interventional Medicine Engineering and Bio…. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, Radiofrequency Ablation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, "Leading Goose" research and development program of Zhejiang Province, National Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiofrequency ablation (RFA) has emerged as a critical therapeutic modality for hepatocellular carcinoma (HCC). Biomimetic magnetic nanoparticles further augment RFA efficacy by enhancing targeting precision and biocompatibility. This study introduces a novel nanocarrier co‐delivery system aimed at key molecular targets in HCC to amplify ferroptosis and reprogram intratumoral immunity, thereby improving the therapeutic outcomes of RFA. The proposed nanocarrier integrates cyclic arginine‐glycine‐aspartic acid (cRGD) and red blood cell membrane (RBCM), encapsulating superparamagnetic iron oxide (SPIO) to specifically target fatty acid‐binding protein 5 (FABP5) in tumor cells. Leveraging the superparamagnetic properties of SPIO, these nanoparticles enable real‐time monitoring and tracking through MRI. In vitro heat treatment of HCC cells simulates the RFA environment, while experiments employing the ferroptosis inhibitor Lipro1 conclusively demonstrate that the nanocarrier exerts anti‐tumor effects primarily through ferroptosis induction. Additionally, the impact on immunotherapy is underscored by combining the nanocarrier with anti‐PD‐L1 monoclonal antibodies. FABP5 overexpression in HCC tissues is strongly linked to RFA response. Targeting FABP5 using co‐delivery nanocarriers significantly enhances RFA efficacy. Furthermore, FABP5 deletion potentiates RFA‐induced ferroptosis and bolsters anti‐tumor immune responses, characterized by increased infiltration of CD8+ T cells and effector memory T cells, contributing to pronounced systemic anti‐tumor effects. Mechanistically, FABP5 inhibition activates the STING/TBK1 signaling pathway and modulates TBK1 protein stability. Notably, the nanocarrier system targeting FABP5 elevates PD‐L1 expression, and the combination of RFA with anti‐PD‐L1 therapy demonstrates synergistic efficacy against HCC. In conclusion, the FABP5‐targeting nanocarrier co‐delivery system offers a promising strategy to enhance RFA effectiveness in HCC, providing a novel framework for advancing clinical treatment approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCarcinoma, HepatocellularLiver NeoplasmsRadiofrequency AblationFatty Acid-Binding ProteinsMembrane ProteinsAnimalsHumansMiceCell Line, TumorSTING Protein

Stichwörter der Autor:innen

FABP5HCCRFASTINGferroptosis

Substanzen

Fatty Acid-Binding ProteinsMembrane ProteinsSTING1 protein, humanSTING Protein

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Imaging and Interventional Medicine, Zhejiang Engineering Research Csaenter of Interventional Medicine Engineering and Biotechnology, The Fifth Affiliated Hospital of Wenzhou Medical Universit…
  • Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, 200000, China.
  • China Medical University, Shenyang, 110122, China.
  • Key Laboratory of Precision Medicine of Lishui City, Department of Radiology, Lishui Central Hospital, Lishui, 323000, China.
  • Department of Radiology, Lishui Hospital, School of Medcine, Zhejiang University, Hangzhou, 310000, China.

ORCID-Profile: Jiansong Ji

Förderung

  • National Natural Science Foundation of China
  • "Leading Goose" research and development program of Zhejiang Province
  • National Natural Science Foundation of Zhejiang Province
  • Key Research and Development project of Lishui City

Zitieren

APA

Tang, B., Zhang, X., Sun, Y., Luo, J., Weng, Q., Zhang, C., Wang, Z., Fang, S., Xiao, Y., Zheng, L., Tu, J., Qiu, R., Yang, Y., Zhao, Z., Chen, W., Chen, M., & Ji, J. (2025). Tumor‐Targeted FABP5/STING Cascade Promote Radiofrequency Ablation Induced Ferroptosis and Intratumoral Immune Rewiring in Hepatocellular Carcinoma. Advanced Science. https://doi.org/10.1002/advs.202507864

Vancouver

Tang B, Zhang X, Sun Y, Luo J, Weng Q, Zhang C, et al. Tumor‐Targeted FABP5/STING Cascade Promote Radiofrequency Ablation Induced Ferroptosis and Intratumoral Immune Rewiring in Hepatocellular Carcinoma. Advanced Science. 2025. doi:10.1002/advs.202507864

BibTeX
@article{Tang2025,
  author = {Tang, Bufu and Zhang, Xiaojie and Sun, Yiting and Luo, Jinhua and Weng, Qiaoyou and Zhang, Cong and Wang, Zilin and Fang, Shiji and Xiao, Yangrui and Zheng, Liyun and Tu, Jianfei and Qiu, Rongfang and Yang, Yang and Zhao, Zhongwei and Chen, Weiqian and Chen, Minjiang and Ji, Jiansong},
  title = {Tumor‐Targeted FABP5/STING Cascade Promote Radiofrequency Ablation Induced Ferroptosis and Intratumoral Immune Rewiring in Hepatocellular Carcinoma},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202507864}
}
Kostenlos starten →